Issue 12/2009
Content (8 Articles)
Cost Effectiveness of Herpes Zoster Vaccine in Canada
Mehdi Najafzadeh, Carlo A. Marra, Eleni Galanis, David M. Patrick
Willingness to Pay for a QALY Based on Community Member and Patient Preferences for Temporary Health States Associated with Herpes Zoster
Tracy A. Lieu, G. Thomas Ray, Ismael R. Ortega-Sanchez, Ken Kleinman, Donna Rusinak
Bayesian Modelling of Healthcare Resource Use in Multinational Randomized Clinical Trials
Aline Gauthier, Andrea Manca, Susan Anton
Healthcare Costs and Obesity Prevention
David R. Rappange, Werner B. F. Brouwer, Rudolf T. Hoogenveen, Pieter H. M. Van Baal
Accounting for the Development of Antibacterial Resistance in the Cost Effectiveness of Ertapenem versus Piperacillin/Tazobactam in the Treatment of Diabetic Foot Infections in the UK
Jeroen P. Jansen, Ritesh Kumar, Yehuda Carmeli